Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study

American Journal of Epidemiology

Volumn 171, Issue 1, 2010, Pages 14-23

  Bressler, Jan ^a   Folsom, Aaron R ^b   Couper, David J ^c   Volcik, Kelly A ^a   Boerwinkle, Eric ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c IL   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Coronary disease; Genetic variation; Genetics; Genomics; Heart diseases; Myocardial infarction; Polymorphism, single nucleotide

Indexed keywords

CARDIOVASCULAR DISEASE; GENETIC VARIATION; GENOMICS; GENOTYPE; HEALTH RISK; POLYMORPHISM;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPEAN UNION; FEMALE; GENETIC VARIABILITY; GENOME ANALYSIS; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RESIDENCE CHARACTERISTICS; RISK; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

UNITED STATES;

EID: 72949122104     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp377     Document Type: Article

References (64)

1. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. International HapMap Consortium. Nature. 2007;449(7164): 851-861
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145): 661-678.
3. Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research. Science. 2007;316(5829): 1331-1336.
4. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829): 1341-1345.
5. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881-885.
6. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39(6):770-775.
7. Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336-1341.
8. Liu YJ, Liu XG, Wang L, et al. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet. 2008;17(12):1803-1813.
9. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits [electronic article]. PLoS Genet. 2007;3(7):e115.
10. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-894.
11. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007; 39(6):724-726.
12. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316(5830):1488-1491.
13. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491-1493. (Pubitemid 46906618)
14. Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer's risk in APOE e4 carriers. Neuron. 2007; 54(5):713-720.
15. Grupe A, Abraham R, Li Y, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet. 2007;16(8):865-873.
16. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320-323.
17. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007; 357(5):443-453. (Pubitemid 47204873)
18. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996;49(2):223-233.
19. The ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
20. Siedel J, Hägele EO, Ziegenhorn J, et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29(6):1075-1080.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
22. 2 precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28(6):1379-1388.
23. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
24. Hintze J. Power Analysis and Sample Size (PASS) [software]. Kaysville, UT: NCSS; 2006.
25. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40(2):189-197.
26. Sandhu MS, Waterworth DM, Debenham SL, et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 2008;371(9611):483-491.
27. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436- 1442.
28. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030 [electronic article]. PLoS Med. 2006;3(11):e442.
29. Motulsky A, Brunzell J. Genetics of coronary artery disease. In: King R, Rotter J, Motulsky A, eds. The Genetic Basis of Common Disease. New York, NY: Oxford University Press; 2002:105-125.
30. Slack J, Evans KA. The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease. J Med Genet. 1966;3(4): 239-257.
31. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106(6):1901-1910.
32. Bleul CC, Fuhlbrigge RC, Casasnovas JM, et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101-1109.
33. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-967.
34. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107(9):1322-1328.
35. Abi-Younes S, Sauty A, Mach F, et al. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res. 2000;86(2): 131-138.
36. Nielsen MS, Jacobsen C, Olivecrona G, et al. Sortilin/neuro-tensin receptor-3 binds and mediates degradation of lipopro-tein lipase. J Biol Chem. 1999;274(13):8832-8836.
37. Burton PR, Hansell AL, Fortier I, et al. Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38(1): 263-273.
38. Altshuler D, Daly M. Guilt beyond a reasonable doubt. Nat Genet. 2007;39(7):813-815.
39. Vincent JB, Skaug J, Scherer SW. The human homologue of flamingo, EGFL2, encodes a brain-expressed large cadherin-like protein with epidermal growth factor-like domains, and maps to chromosome 1p13.3-p21.1. DNA Res. 2000;7(3):233-235.
40. Shima Y, Kengaku M, Hirano T, et al. Regulation of dendritic maintenance and growth by a mammalian 7-pass transmem-brane cadherin. Dev Cell. 2004;7(2):205-216.
41. Hsieh WJ, Hsieh SC, Chen CC, et al. Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage. Bio-chem Biophys Res Commun. 2008;369(2):567-572.
42. Morris NJ, Ross SA, Lane WS, et al. Sortilin is the major 110-kDa protein in GLUT4 vesicles from adipocytes. J Biol Chem. 1998;273(6):3582-3587.
43. Shi J, Kandror KV. Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes. Dev Cell. 2005;9(1):99-108.
44. Bosserhoff AK, Buettner R. Expression, function and clinical relevance of MIA (melanoma inhibitory activity). Histol Histopathol. 2002;17(1):289-300.
45. Arndt S, Bosserhoff AK. TANGO is a tumor suppressor of malignant melanoma. Int J Cancer. 2006;119(12):2812-2820.
46. Leader B, Leder P. Formin-2, a novel formin homology protein of the cappuccino subfamily, is highly expressed in the developing and adult central nervous system. Mech Dev. 2000; 93(1-2):221-231.
47. Leader B, Lim H, Carabatsos MJ, et al. Formin-2, polyploidy, hypofertility and positioning of the meiotic spindle in mouse oocytes. Nat Cell Biol. 2002;4(12):921-928.
48. Prasannan P, Pike S, Peng K, et al. Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls. J Biol Chem. 2003;278(44):43178-43187.
49. Walkup AS, Appling DR. Enzymatic characterization of human mitochondrial C1-tetrahydrofolate synthase. Arch Bio-chem Biophys. 2005;442(2):196-205.
50. McCully KS. Homocysteine and vascular disease. Nat Med. 1996;2(4):386-389.
51. Sherr CJ. The Pezcoller Lecture: cancer cell cycles revisited. Cancer Res. 2000;60(14):3689-3695.
52. INK4B is a potential effector of TGF-b-induced cell cycle arrest [letter]. Nature. 1994;371(6494): 257-261.
53. Pasmant E, Laurendeau I, Héron D, et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007;67(8):3963-3969.
54. Yokote K, Kobayashi K, Saito Y. The role of Smad3-dependent TGF-b signal in vascular response to injury. Trends Cardiovasc Med. 2006;16(7):240-245.
55. Kalinina N, Agrotis A, Antropova Y, et al. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-b/ Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler Thromb Vasc Biol. 2004;24(8):1391-1396.
56. Edlin RS, Tsai S, Yamanouchi D, et al. Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: potential role of Smad3 in regulation of SMC proliferation. J Vasc Surg. 2009;49(5):1289-1295.
57. Hug C, Wang J, Ahmad NS, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/ adiponectin. Proc Natl Acad Sci U S A. 2004;101(28):10308-10313.
58. Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring). 2009;17(4):737-744.
59. Org E, Eyheramendy S, Juhanson P, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet. 2009;18(12):2288-2296.
60. Ivanov D, Philippova M, Tkachuk V, et al. Cell adhesion molecule T-cadherin regulates vascular cell adhesion, pheno-type and motility. Exp Cell Res. 2004;293(2):207-218.
61. Jarrous N, Eder PS, Wesolowski D, et al. Rpp14 and Rpp29, two protein subunits of human ribonuclease P. RNA. 1999; 5(2):153-157.
62. van Eenennaam H, Pruijn GJ, van Venrooij WJ. hPop4: a new protein subunit of the human RNase MRP and RNase P ribo-nucleoprotein complexes. Nucleic Acids Res. 1999;27(12): 2465-2472.
63. Nishioka M, Kohno T, Takahashi M, et al. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line. Oncogene. 2000; 19(54):6251-6260.
64. Gorlov IP, Meyer P, Liloglou T, et al. Seizure 6-like (SEZ6L) gene and risk for lung cancer. Cancer Res. 2007;67(17): 8406-8411.